CHICAGO (Reuters) - After years of uncertainty, a nearly decade-long study showed that Merck & Co's cholesterol drug Zetia lowered the risk of heart attacks and strokes in high-risk heart patients ...
YouTube on MSNOpinion
A concise masterclass on cholesterol-lowering medications
A concise, high-yield guide to cholesterol-lowering therapies—statins, Zetia, PCSK9 inhibitors, bempedoic acid, berberine, ...
NEW ORLEANS, November 8, 2004 – Results from a new study showed that coadministration of ZETIA® (ezetimibe) and fenofibrate significantly reduced LDL ("bad") cholesterol (LDL-C), non-high density ...
A new study raises fresh concerns about Zetia and its cousin, Vytorin — drugs still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work.
This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. A comprehensive review of previous studies involving the ...
ORLANDO, Fla. -- A new study raises fresh concerns about Zetia and its cousin, Vytorin -- drugs still taken by millions of Americans to lower cholesterol, despite questions raised last year about how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results